Peter Lunny, M.D.
Internal Medicine · Nephrology (CMS) · Fremont, CA
At a glance
1999 Mowry Ave, Fremont, CA 94538-1738
NPPES record updated Nov 3, 2022. Public records can lag behind changes at a practice.
Before you call: a quick checklist
- Are you accepting new patients?
- Do you accept my specific insurance plan?
- Do you provide the service I need at this address?
- Do I need a referral, and what is the earliest appointment?
Insurance participation and appointment availability are not established by these public records.
Medicare & insurance
Insurance participation is not established by these public records. Ask the practice and your insurer about your specific plan and this location.
How to check your coverage
Use your plan’s provider directory or the member-services number on your insurance card. Confirm the clinician, practice address, service, and whether a referral is required. A missing opt-out record does not establish Medicare acceptance.
Check the official Medicare directory ↗Practice location
1999 Mowry Ave Suite RFremont, CA 94538-1738
Additional reported practice locations
27200 Calaroga AveHayward, CA 945454339
Phone: 5103519373
Fax: 5103510616
Education & affiliations
- Medical / professional school
- Warren Alpert Medical School Of Brown University
- Graduation year
- 1989
- CMS specialties
- Internal Medicine · Nephrology
CMS reports telehealth services for this clinician. Confirm current services and availability with the practice.
Practice groups
Reported hospital affiliations
- Eden Medical Center Castro Valley, CA
- Highland Hospital Oakland, CA
- St Rose Hospital Hayward, CA
- Washington Hospital Fremont, CA
Graduation year does not establish years in practice. A reported affiliation does not establish employment, current admitting privileges, or insurance participation.
Source: CMS National Downloadable File · Published Oct 15, 2026.
Source: CMS Facility Affiliation Data · Published Oct 15, 2026.
Procedures in the public data
Reported activity can help you ask more informed questions about a practice’s services.
No displayed procedure-category record in this release. This does not mean the clinician performs no procedures.
CMS uses a one-year claims window with a reporting lag. Counts cover the Medicare activity included by CMS, not all patients. “1–10” is a published range. Volume is not a quality or outcomes score. Coverage and methodology
Source: CMS Utilization Data · Published Oct 15, 2026.
Find providers with a similar service mix
Compare 2024 published Medicare activity in the same reported specialty, here or in another city.
Reported clinician measures
Measures below describe reported clinician performance in the stated period. They do not form an overall HCPList rating, and reporting differs between clinicians.
Published clinical measures
- Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
- 26%2024Published MIPS performance rate. Lower rates indicate better performance for this inverse measure. Measure: MIPS_EC_001_overall. Collection type: EHR. Measure denominator: 162.
- Advance Care Plan
- 10%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_047_overall. Collection type: REG. Measure denominator: 684.
- Diabetes: Eye Exam
- 0%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_117_overall. Collection type: EHR. Measure denominator: 162.
See all 12 reported measures
- Documentation of Current Medications in the Medical Record
- 82%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_130_overall. Collection type: EHR. Measure denominator: 1849.
- Preventive Care and Screening: Screening for Depression and Follow-Up Plan
- 2%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_134_overall. Collection type: EHR. Measure denominator: 560.
- Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
- 85%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_226_performance. Collection type: EHR. Measure denominator: 20.
- Controlling High Blood Pressure
- 74%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_236_overall. Collection type: REG. Measure denominator: 387.
- Use of High-Risk Medications in Older Adults
- 0%2024Published MIPS performance rate. Lower rates indicate better performance for this inverse measure. Measure: MIPS_EC_238_overall. Collection type: EHR. Measure denominator: 418.
- Cervical Cancer Screening
- 0%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_309_overall. Collection type: EHR. Measure denominator: 54.
- Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
- 55%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_317_overall. Collection type: EHR. Measure denominator: 137.
- Falls: Screening for Future Fall Risk
- 0%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_318_overall. Collection type: EHR. Measure denominator: 403.
- Closing the Referral Loop: Receipt of Specialist Report
- 46%2024Published MIPS performance rate. Higher rates indicate better performance for this measure. Measure: MIPS_EC_374_overall. Collection type: EHR. Measure denominator: 46.
Source: PY 2024 Clinician Public Reporting: MIPS Measures and Attestations · Published Sep 10, 2026.
Industry-reported general payments
Includes reported transfers of value, such as meals, travel, or consulting. Payments do not establish improper conduct or quality of care. Research funding and ownership values are excluded from this total.
See payment purposes and reporting companies
Reported purposes
| Purpose | Amount |
|---|---|
| Food and beverage | $869.59 |
Reporting companies
| Company | Amount |
|---|---|
| AMGEN INC. | $160.58 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $118.41 |
| FRESENIUS USA MARKETING, INC. | $95.23 |
| NOVO NORDISK INC | $94.56 |
| GLAXOSMITHKLINE, LLC. | $83.88 |
| MALLINCKRODT HOSPITAL PRODUCTS INC. | $77.94 |
| ASTRAZENECA PHARMACEUTICALS LP | $65.25 |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | $31.06 |
| Other reporting companies | $142.68 |
Source: CMS 2025 payments grouped by covered recipient and nature of payments · Published Jun 30, 2026.
Professional details: NPI, taxonomy & registry record
Registry details
- Primary taxonomy
- Internal Medicine · Nephrology (CMS)
- Taxonomy code
- 207RN0300X
- Enumeration date
- May 27, 2006
- Record updated
- Nov 3, 2022
More registry details
- Provider type
- Individual · Type 1
- Other reported name
- PETER LUNNY
- Reported credentials
- M.D.
Reported taxonomies and licenses
174400000X
License reported: G69757 CA
207RN0300X · Primary
License reported: G69757 CA
License numbers and credentials are reported to NPPES; HCPList does not independently verify them.
Practice location
1999 Mowry AveSuite R
Fremont, CA 94538-1738
- Phone
- (510) 745-8186
- Fax
- (510) 745-8332
Mailing address
1999 MOWRY AVESUITE R
FREMONT, CA 945381738
Information may be outdated or incomplete. Confirm details directly with the practice. HCPList is an independent directory and is not affiliated with CMS.
Report a directory issue